The Amphipathic GM1 Molecule Stabilizes Amyloid Aggregates, Preventing their Cytotoxicity.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
21 07 2020
Historique:
received: 10 07 2019
revised: 20 05 2020
accepted: 02 06 2020
pubmed: 25 6 2020
medline: 15 5 2021
entrez: 25 6 2020
Statut: ppublish

Résumé

Amyloid aggregates have been demonstrated to exert cytotoxic effects in several diseases. It is widely accepted that the complex and fascinating aggregation pathway involves a series of steps during which many heterogeneous intermediates are generated. This process may be greatly potentiated by the presence of amphipathic components of plasma membrane because they may serve as interaction, condensation, and nucleation points. However, there are few data regarding structural alterations induced by the binding between the amyloid fibrils and membrane components and its direct effects on cell integrity. In this study, we found, by 1-anilinonaphthalene 8-sulfonic acid and transmission electron microscopy/fast Fourier transform, that yeast prion Sup35 oligomers showed higher structural uniformity and altered surface properties when grown in the presence of monosialotetrahexosylganglioside, a component of the cell membrane. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and confocal/sensitized Förster resonance energy transfer analyses revealed that these fibrils showed low cytotoxicity and affinity to plasma membrane. Moreover, time-lapse analysis of Sup35 oligomer fibrillation on cells suggested that the amyloid aggregation process per se exerts cytotoxic effects through the interaction of amyloid intermediates with plasma membrane components. These data provide, to our knowledge, new insights to understand the mechanism of amyloid growth and cytotoxicity in the pathogenesis of amyloid diseases.

Identifiants

pubmed: 32579964
pii: S0006-3495(20)30477-X
doi: 10.1016/j.bpj.2020.06.005
pmc: PMC7376221
pii:
doi:

Substances chimiques

Amyloid 0
Peptide Termination Factors 0
SUP35 protein, S cerevisiae 0
Saccharomyces cerevisiae Proteins 0
G(M1) Ganglioside 37758-47-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

326-336

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Références

Biochemistry. 2007 Feb 20;46(7):1913-24
pubmed: 17256880
J Biol Chem. 2008 Oct 31;283(44):29950-60
pubmed: 18676369
J Biol Chem. 2015 Jan 30;290(5):2969-82
pubmed: 25425650
Chembiochem. 2011 Jul 25;12(11):1749-58
pubmed: 21671331
Cell. 2012 Mar 16;148(6):1188-203
pubmed: 22424229
J Phys Chem Lett. 2014 Feb 6;5(3):517-27
pubmed: 26276603
J Biol Chem. 2012 May 11;287(20):16947-54
pubmed: 22461629
Chem Commun (Camb). 2018 Aug 11;54(62):8637-8640
pubmed: 30020284
J Biol Chem. 2001 Jul 6;276(27):24985-90
pubmed: 11342534
Naturwissenschaften. 2013 Mar;100(3):209-18
pubmed: 23334407
Biophys J. 2006 Dec 15;91(12):4575-88
pubmed: 16997875
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):459-75
pubmed: 23040361
Food Chem Toxicol. 2019 Jul;129:1-12
pubmed: 30995514
Curr Alzheimer Res. 2011 Dec;8(8):841-52
pubmed: 21592051
Biochim Biophys Acta. 2016 Feb;1858(2):386-92
pubmed: 26656159
Neuron. 2017 Jul 5;95(1):33-50
pubmed: 28683268
Langmuir. 2017 Dec 5;33(48):13874-13881
pubmed: 29148800
FEBS Lett. 2006 Jun 12;580(14):3451-6
pubmed: 16716307
PLoS One. 2010 Feb 05;5(2):e9079
pubmed: 20140095
ACS Chem Neurosci. 2014 Apr 16;5(4):266-74
pubmed: 24475785
J Neurosci Res. 2012 Oct;90(10):1997-2008
pubmed: 22714832
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Int J Mol Sci. 2019 Dec 20;21(1):
pubmed: 31861839
Sci Rep. 2013 Sep 27;3:2781
pubmed: 24071712
J Neurochem. 2007 Jan;100(2):446-57
pubmed: 17076759
FEBS Lett. 2013 May 2;587(9):1385-91
pubmed: 23523632
Curr Alzheimer Res. 2018;15(13):1191-1212
pubmed: 30207230
Int J Mol Sci. 2013 Jun 13;14(6):12411-57
pubmed: 23765219
Glycoconj J. 2015 May;32(3-4):87-91
pubmed: 25903682
Biochim Biophys Acta Biomembr. 2018 Sep;1860(9):1863-1875
pubmed: 29702073
Biochim Biophys Acta. 2008 Dec;1778(12):2717-26
pubmed: 18727916
J Nutr Biochem. 2016 Apr;30:153-66
pubmed: 27012632
Nat Commun. 2014 Jul 15;5:4384
pubmed: 25023996
Sci Rep. 2018 Aug 17;8(1):12367
pubmed: 30120270
Biochim Biophys Acta. 2010 Apr;1802(4):406-15
pubmed: 20060899
J Phys Chem B. 2013 Jul 11;117(27):8085-94
pubmed: 23688073
J Cell Mol Med. 2016 Aug;20(8):1443-56
pubmed: 26990223
Biochem J. 1988 Apr 15;251(2):613-6
pubmed: 3401219
Membranes (Basel). 2017 Aug 31;7(3):
pubmed: 28858214
J Neurochem. 2007 Jul;102(2):398-407
pubmed: 17472702
Biochim Biophys Acta. 2013 Dec;1833(12):3155-3165
pubmed: 24035922
J Biol Chem. 2007 Jan 19;282(3):1679-86
pubmed: 17121860
FASEB J. 2012 Feb;26(2):818-31
pubmed: 22071505
J Biol Chem. 2007 Apr 13;282(15):11590-601
pubmed: 17308309
Sci Rep. 2016 Sep 13;6:32721
pubmed: 27619987
Nat Neurosci. 2008 May;11(5):547-54
pubmed: 18391946
Neuron. 2014 Apr 16;82(2):308-19
pubmed: 24685176
ACS Chem Biol. 2014 Oct 17;9(10):2309-17
pubmed: 25079908
J Am Chem Soc. 2011 Aug 10;133(31):12001-8
pubmed: 21721557
FEBS J. 2010 Nov;277(22):4602-13
pubmed: 20977664
Phys Chem Chem Phys. 2013 Jun 21;15(23):8929-39
pubmed: 23515399
Semin Cell Dev Biol. 2018 Jan;73:82-94
pubmed: 28860102
J Clin Invest. 2013 Jul;123(7):2791-802
pubmed: 23921129
J Cell Biol. 2010 Jul 26;190(2):223-31
pubmed: 20643880
EMBO J. 2006 Feb 22;25(4):822-33
pubmed: 16467849
Biochemistry. 2011 Mar 29;50(12):2061-71
pubmed: 21288003
Mol Cell. 2004 Apr 23;14(2):233-45
pubmed: 15099522
Neurochem Res. 2007 Aug;32(8):1302-13
pubmed: 17401655
J Neurosci. 2010 Mar 17;30(11):4072-80
pubmed: 20237277
Acc Chem Res. 2014 Aug 19;47(8):2397-404
pubmed: 25029558

Auteurs

Monica Bucciantini (M)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy. Electronic address: monica.bucciantini@unifi.it.

Manuela Leri (M)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy; Department of Neuroscience, Psychology, Area of Medicine and Health of the Child of the University of Florence, Florence, Italy.

Massimo Stefani (M)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy.

Ronald Melki (R)

Institut Francois Jacob, CEA and Laboratory of Neurodegenerative Diseases, CNRS 92265, Fontenay-Aux-Roses, France.

Sandra Zecchi-Orlandini (S)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Daniele Nosi (D)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Articles similaires

alpha-Synuclein Humans Animals Mice Lewy Body Disease
Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase
Humans Animals Adherens Junctions Intercellular Junctions Tight Junctions

Classifications MeSH